Skip to main content
John Tole II, DO, Allergy & Immunology, Auburn, AL, East Alabama Medical Center

JohnWinchesterToleIIDOFACAAI

Allergy & Immunology Auburn, AL

Asthma & Allergic Conditions

East Alabama Allergy and Asthma, PLLC

Dr. Tole is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Tole's full profile

Already have an account?

Education & Training

  • University of Mississippi Medical Center
    University of Mississippi Medical CenterFellowship, Allergy and Immunology, 2008 - 2010
  • University of Tennessee
    University of TennesseeChief Residency, Internal Medicine, 2007 - 2008
  • University of Tennessee
    University of TennesseeResidency, Internal Medicine, 2004 - 2007
  • Nova Southeastern University College of Osteopathic Medicine
    Nova Southeastern University College of Osteopathic MedicineClass of 2003
  • Auburn University
    Auburn UniversityBS, Microbiology, Magna Cum Laude, 1998

Certifications & Licensure

  • FL State Medical License
    FL State License 2023 - 2026
  • GA State Medical License
    GA State License 2023 - 2025
  • MS State Medical License
    MS State License 2008 - 2025
  • AL State Medical License
    AL State License 2010 - 2024
  • TN State Medical License
    TN State License 2007 - 2010
  • American Board of Allergy and Immunology Allergy & Immunology

Awards, Honors, & Recognition

  • Fellow American College of Allergy, Asthma, and Immunology ACAAI, 2013
  • CMS Meaningful Use Stage 1 Certification Practice Fusion EHR, Practice Fusion, Inc., 2011-2013
  • America’s Top Physicians 2009
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Effect of Psychological Stress Intervention for Patients with Chronic Urticaria.  
    J.W. Tole et al, J Allergy Clin Immunol. 2011 Feb; 127 (2): Supplement, Pg AB104
  • Omalizumab Downregulates the Expression of CD23 (FceRII) on Human Bronchial Smooth Muscle Cells (HBSMC) in Vitro.  
    M.R. Streck, J. Tole, R.K. Gandhi, T.M. Loun, C.W. Stewart and D.B. Lew, J Allergy Clin Immunol. 2006 February; 117 (2): S9

Press Mentions

  • US Investors Set up Sh200 Million Hospital in Nairobi
    US Investors Set up Sh200 Million Hospital in NairobiFebruary 10th, 2021

Committees

  • Member, Practice Management Committee 2012 - Present

Professional Memberships

Hospital Affiliations